Escherichia coli on colorectal cancer: A two‐edged sword

Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two‐edged sword theory was innovatively proposed. For the question ‘how can we harness the ambivalent nature of E. coli to scre...

Full description

Saved in:
Bibliographic Details
Published inMicrobial biotechnology Vol. 17; no. 10; pp. e70029 - n/a
Main Authors Jian, Chu, Yinhang, Wu, Jing, Zhuang, Zhanbo, Qu, Zefeng, Wang, Shuwen, Han
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.10.2024
John Wiley and Sons Inc
Wiley
Subjects
Antigens
Bacteria
Biofilms
Biomarkers
Cancer therapies
Coliforms
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - microbiology
DNA methylation
E coli
Environmental factors
Escherichia coli
Escherichia coli - genetics
Gastrointestinal Microbiome
Genes
Genetic engineering
Genomes
Humans
Immunotherapy
Metabolism
Metabolites
Metastasis
Microflora
Microorganisms
Nanoparticles
Phylogenetics
Polymorphism
Probiotics
Review
Science
Tumors
Online AccessGet full text

Cover

Abstract Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two‐edged sword theory was innovatively proposed. For the question ‘how can we harness the ambivalent nature of E. coli to screen and treat CRC?’, in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli, particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the ‘One Health’ view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two‐edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment. This review discusses Escherichia coli's (E. coli) dual role in colorectal cancer (CRC) via metabolites, immune modulation, and biofilm formation. It explores E. coli as a CRC biomarker and its therapeutic potential, highlighting its use in integrating advanced technologies for research.
AbstractList Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two‐edged sword theory was innovatively proposed. For the question ‘how can we harness the ambivalent nature of E. coli to screen and treat CRC?’, in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli, particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the ‘One Health’ view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two‐edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment. This review discusses Escherichia coli's (E. coli) dual role in colorectal cancer (CRC) via metabolites, immune modulation, and biofilm formation. It explores E. coli as a CRC biomarker and its therapeutic potential, highlighting its use in integrating advanced technologies for research.
Escherichia coli ( E. coli ) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two‐edged sword theory was innovatively proposed. For the question ‘how can we harness the ambivalent nature of E. coli to screen and treat CRC?’, in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli , particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the ‘One Health’ view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two‐edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment. This review discusses Escherichia coli 's ( E. coli ) dual role in colorectal cancer (CRC) via metabolites, immune modulation, and biofilm formation. It explores E. coli as a CRC biomarker and its therapeutic potential, highlighting its use in integrating advanced technologies for research.
Escherichia coli ( E. coli ) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two‐edged sword theory was innovatively proposed. For the question ‘how can we harness the ambivalent nature of E. coli to screen and treat CRC?’, in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli , particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the ‘One Health’ view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two‐edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment.
Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two-edged sword theory was innovatively proposed. For the question 'how can we harness the ambivalent nature of E. coli to screen and treat CRC?', in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli, particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the 'One Health' view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two-edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment.
Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two-edged sword theory was innovatively proposed. For the question 'how can we harness the ambivalent nature of E. coli to screen and treat CRC?', in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli, particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the 'One Health' view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two-edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment.Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two-edged sword theory was innovatively proposed. For the question 'how can we harness the ambivalent nature of E. coli to screen and treat CRC?', in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli, particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the 'One Health' view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two-edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment.
Abstract Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In this review, the two‐edged sword theory was innovatively proposed. For the question ‘how can we harness the ambivalent nature of E. coli to screen and treat CRC?’, in terms of CRC screening, the variations in the abundance and subtypes of E. coli across different populations present an opportunity to utilise it as a biomarker, while in terms of CRC treatment, the natural beneficial effect of E. coli on CRC may be limited, and engineered E. coli, particularly certain subtypes with probiotic potential, can indeed play a significant role in CRC treatment. It seems that the favourable role of E. coli as a genetic tool lies not in its direct impact on CRC but its potential as a research platform that can be integrated with various technologies such as nanoparticles, imaging methods, and synthetic biology modification. The relationship between gut microflora and CRC remains unclear due to the complex diversity and interaction of gut microflora. Therefore, the application of E. coli should be based on the ‘One Health’ view and take the interactions between E. coli and other microorganisms, host, and environmental factors, as well as its own changes into account. In this paper, the two‐edged sword role of E. coli in CRC is emphasised to realise the great potential of E. coli in CRC screening and treatment.
Author Jian, Chu
Zhanbo, Qu
Jing, Zhuang
Shuwen, Han
Yinhang, Wu
Zefeng, Wang
AuthorAffiliation 5 ASIR (Institute ‐ Association of intelligent systems and robotics) Rueil‐Malmaison France
1 Huzhou Central Hospital Affiliated Central Hospital Huzhou University Huzhou Zhejiang People's Republic of China
2 Huzhou Central Hospital Fifth Affiliated Clinical Medical College of Zhejiang Chinese Medical University Huzhou Zhejiang People's Republic of China
4 Huzhou University Huzhou Zhejiang People's Republic of China
3 Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou Huzhou Zhejiang People's Republic of China
AuthorAffiliation_xml – name: 2 Huzhou Central Hospital Fifth Affiliated Clinical Medical College of Zhejiang Chinese Medical University Huzhou Zhejiang People's Republic of China
– name: 5 ASIR (Institute ‐ Association of intelligent systems and robotics) Rueil‐Malmaison France
– name: 4 Huzhou University Huzhou Zhejiang People's Republic of China
– name: 3 Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou Huzhou Zhejiang People's Republic of China
– name: 1 Huzhou Central Hospital Affiliated Central Hospital Huzhou University Huzhou Zhejiang People's Republic of China
Author_xml – sequence: 1
  givenname: Chu
  surname: Jian
  fullname: Jian, Chu
  organization: Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou
– sequence: 2
  givenname: Wu
  surname: Yinhang
  fullname: Yinhang, Wu
  organization: Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou
– sequence: 3
  givenname: Zhuang
  surname: Jing
  fullname: Jing, Zhuang
  organization: Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou
– sequence: 4
  givenname: Qu
  surname: Zhanbo
  fullname: Zhanbo, Qu
  organization: Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou
– sequence: 5
  givenname: Wang
  surname: Zefeng
  fullname: Zefeng, Wang
  organization: Huzhou University
– sequence: 6
  givenname: Han
  orcidid: 0000-0001-6180-9565
  surname: Shuwen
  fullname: Shuwen, Han
  email: shuwenhan985@163.com
  organization: ASIR (Institute ‐ Association of intelligent systems and robotics)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39400440$$D View this record in MEDLINE/PubMed
BookMark eNqFUj1vFDEQtVAQ-YCaDq1EQ3OJxx-7dhoUogCRgmhCbdmzvjuffOtg73FKx0_gN_JL2M2GU5IC3Iw1fu_NjN8ckr0udZ6Q10CPYTgn0EiYNRrkcUMp08_IwS6z9-C-Tw5LWVFaUyrZC7LPtaBUCHpATi8KLn0OuAy2whRDlboxpuyxt7FC26HPp9VZ1W_T75-_fLvwbVW2KbcvyfO5jcW_uo9H5NvHi-vzz7Orr58uz8-uZii51DPPhGuQKUmFcn6uBZetZ9Yxp4Fr3jaaWQY1Kmw451ZJhcgoaOqodsAFPyKXk26b7Mrc5LC2-dYkG8xdIuWFsbkPGL0RoraoatY4NVZDq50etCnHua1B8EHr_aR1s3Fr36Lv-mzjI9HHL11YmkX6YQBEw2oJg8K7e4Wcvm986c06FPQx2s6nTTEcoOZcaS0H6Nsn0FXa5G74qwHFQAIoNY735mFLu17-ejQATiYA5lRK9vMdBKgZt8CMPpvRZ3O3BQNDPmFg6G0f0jhTiP_g1RNvG6K__V8Z8-XDNZuIfwANG8HH
CitedBy_id crossref_primary_10_1016_j_intimp_2024_113666
crossref_primary_10_1111_1751_7915_70080
crossref_primary_10_1111_1751_7915_70090
Cites_doi 10.1084/jem.20181939
10.1021/es201599u
10.1186/s40169-018-0209-2
10.1128/mBio.03634-20
10.5483/BMBRep.2021.54.8.060
10.1038/s41467-023-43329-5
10.3390/microorganisms10010102
10.1016/j.molmed.2016.11.004
10.1016/j.tips.2022.02.002
10.1080/19490976.2022.2110822
10.1128/mSphere.01195-20
10.1128/AAC.00744-09
10.1080/21505594.2022.2097417
10.1007/s11274-022-03314-4
10.1111/1751-7915.14474
10.1158/0008-5472.CAN-10-2833
10.1136/jitc-2021-003939
10.1042/BST20190558
10.1126/scitranslmed.aax0876
10.1021/acs.est.0c04968
10.1128/mbio.03814-21
10.1073/pnas.1406199111
10.1080/19490976.2015.1121363
10.3390/ijerph191811825
10.1002/advs.202207366
10.1126/science.aax9181
10.1128/genomeA.00385-18
10.1042/CS20160876
10.1038/s41467-020-15030-4
10.1186/s12920-020-0704-3
10.3390/microorganisms8111712
10.1128/mSystems.00289-19
10.1007/s13238-020-00813-8
10.1155/2021/1171239
10.1139/cjm-2020-0508
10.1038/s41586-022-04444-3
10.12659/MSM.904220
10.1016/j.bbcan.2019.05.009
10.1093/femsre/fuz028
10.1038/s41586-020-2080-8
10.1016/j.lfs.2023.121709
10.1126/science.aar7785
10.1126/sciadv.abo6163
10.1016/j.ccell.2024.02.009
10.3389/fimmu.2023.1213467
10.3748/wjg.v20.i21.6560
10.1126/scisignal.abm0488
10.1016/j.celrep.2020.01.078
10.3389/fcimb.2020.548492
10.1111/1751-7915.14477
10.1371/journal.pone.0228217
10.1016/j.dnarep.2020.103009
10.1016/j.chom.2022.08.004
10.1556/1886.2016.00029
10.1002/ijc.32920
10.1186/s12879-014-0733-7
10.1126/science.aah3648
10.1080/01635581.2015.990570
10.1038/nature17626
10.1371/journal.pone.0056964
10.1038/s41467-021-24331-1
10.1002/ijc.29567
10.1126/science.277.5331.1453
10.1016/j.cell.2016.04.007
10.1128/jcm.35.5.1103-1107.1997
10.1126/science.abm3233
10.1007/BF02931286
10.1016/j.cell.2022.06.050
10.1038/s41575-019-0126-x
10.1111/jgh.15077
10.1016/j.cub.2024.04.025
10.1099/mgen.0.000579
10.1128/AAC.00402-21
10.1038/nrmicro2819
10.1016/j.tim.2022.05.010
10.7150/thno.42121
10.1128/microbiolspec.AME-0014-2020
10.1080/1040841X.2018.1481013
10.1093/ibd/izaa047
10.1002/btm2.10219
10.1038/s41575-020-00397-y
10.1128/AAC.00765-10
10.1016/j.ejmech.2022.114291
10.7150/thno.20359
10.1038/s41579-022-00779-w
10.1053/j.gastro.2022.06.054
10.1126/science.1224820
10.1016/j.chom.2023.01.013
10.1111/j.1365-2958.2006.05172.x
10.1007/s00253-018-9420-8
10.1039/D2FO00226D
10.1371/journal.ppat.1008029
10.1053/j.gastro.2021.06.024
10.3389/fimmu.2022.748839
10.1099/mic.0.001063
10.1093/nar/gkz242
10.1038/ncomms5724
10.1016/j.celrep.2023.112754
10.3390/ijms21093062
10.3390/pharmaceutics13081226
10.3390/cancers12082272
10.1016/j.tim.2018.08.009
10.1038/s41418-019-0312-y
10.1111/1751-7915.14461
10.1016/j.tranon.2022.101598
10.1074/jbc.M117.796631
10.1038/s41579-020-0416-x
10.1126/science.1127059
10.1038/s41564-020-0773-2
10.1128/mSphere.00624-21
10.1016/j.mtbio.2023.100543
10.1172/JCI124196
10.1186/s12885-021-07845-1
10.3389/fcimb.2022.938477
10.1111/cas.15196
10.1016/j.chom.2021.02.007
10.1016/j.trecan.2022.08.003
10.1038/s41591-019-0498-z
10.1038/s41467-022-34390-7
10.1016/j.ccell.2021.03.004
10.1016/j.jgar.2021.10.022
10.1038/labinvest.2014.161
10.3322/caac.21772
10.1126/science.276.5312.607
10.3390/bioengineering10101188
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Ltd.
2024 The Author(s). Microbial Biotechnology published by John Wiley & Sons Ltd.
2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Ltd.
– notice: 2024 The Author(s). Microbial Biotechnology published by John Wiley & Sons Ltd.
– notice: 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7T7
7X7
7XB
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
LK8
M0S
M7P
M7S
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
RC3
7X8
5PM
DOA
DOI 10.1111/1751-7915.70029
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Biological Science Database
Engineering Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ - Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Genetics Abstracts
ProQuest Engineering Collection
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
Engineering Collection
Engineering Database
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
DocumentTitleAlternate Escherichia coli and colorectal cancer
EISSN 1751-7915
EndPage n/a
ExternalDocumentID oai_doaj_org_article_446ac8627b8048bca9b921603cfa6143
PMC11472651
1011111751791570029
39400440
10_1111_1751_7915_70029
MBT270029
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: China University Industry University Research Innovation Fund
  funderid: 2023HT078
– fundername: Medical Science and Technology Project of Zhejiang Province
  funderid: 2023GY04
– fundername: Public Welfare Technology Application Research Program of Huzhou
  funderid: 2023GZ86
– fundername: Medical Science and Technology Project of Zhejiang Province
  grantid: 2023GY04
– fundername: China University Industry University Research Innovation Fund
  grantid: 2023HT078
– fundername: Public Welfare Technology Application Research Program of Huzhou
  grantid: 2023GZ86
GroupedDBID ---
0R~
123
1OC
24P
29M
31~
4.4
53G
5DZ
5VS
7X7
8-1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAHHS
AANHP
AAZKR
ABDBF
ABJCF
ABUWG
ACBWZ
ACCFJ
ACCMX
ACGFO
ACIWK
ACPRK
ACRPL
ACUHS
ACXQS
ACYXJ
ADBBV
ADKYN
ADNMO
ADPDF
ADRAZ
ADZMN
AEEZP
AEGXH
AENEX
AEQDE
AEUYN
AFKRA
AFRAH
AHMBA
AIAGR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
ASPBG
AVUZU
AVWKF
AZFZN
BAWUL
BBNVY
BCNDV
BDRZF
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
D-9
DIK
EBD
EBS
EJD
EMOBN
ESX
F5P
FEDTE
FYUFA
GODZA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HVGLF
HYE
IAO
IHR
ITC
KQ8
L6V
LH4
LK8
LW6
M48
M7P
M7S
ML0
MM.
O9-
OIG
OK1
OVD
OVEED
P2P
PIMPY
PQQKQ
PROAC
PTHSS
RNS
RPM
SV3
TEORI
TUS
UKHRP
WIN
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PQGLB
3V.
7QO
7T7
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c5359-e24b7c285048bef9435de2ab2b91393d792a216c8c7333a858cc20190b09b1343
IEDL.DBID M48
ISSN 1751-7915
IngestDate Wed Aug 27 01:20:42 EDT 2025
Thu Aug 21 18:34:54 EDT 2025
Fri Jul 11 12:17:59 EDT 2025
Wed Aug 13 04:23:59 EDT 2025
Mon Jul 21 05:56:01 EDT 2025
Thu Apr 24 22:56:14 EDT 2025
Tue Jul 01 03:38:06 EDT 2025
Wed Jan 22 17:13:15 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Attribution-NonCommercial-NoDerivs
2024 The Author(s). Microbial Biotechnology published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5359-e24b7c285048bef9435de2ab2b91393d792a216c8c7333a858cc20190b09b1343
Notes Chu Jian, Wu Yinhang and Zhuang Jing contributed equally to this work and should be considered co‐first authors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6180-9565
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1111/1751-7915.70029
PMID 39400440
PQID 3121511884
PQPubID 1016378
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_446ac8627b8048bca9b921603cfa6143
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11472651
proquest_miscellaneous_3116338995
proquest_journals_3121511884
pubmed_primary_39400440
crossref_primary_10_1111_1751_7915_70029
crossref_citationtrail_10_1111_1751_7915_70029
wiley_primary_10_1111_1751_7915_70029_MBT270029
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2024
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: October 2024
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bedford
– name: Hoboken
PublicationTitle Microbial biotechnology
PublicationTitleAlternate Microb Biotechnol
PublicationYear 2024
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2023; 73
2021; 65
2021; 67
2021; 167
1997; 276
2019; 15
1997; 277
2019; 16
2020; 15
2011; 55
2021; 161
2020; 13
2020; 12
2024; 34
2020; 11
2020; 10
2013; 8
2018; 44
2012; 10
2022; 29
2014; 20
2018; 7
2018; 6
2022; 163
2018; 293
2015; 137
2011; 71
2022; 1877
2019; 26
2019; 25
2019; 27
2003; 48
2014; 14
2022; 30
2022; 603
2022; 38
2021; 2021
2019; 4
2018; 102
2023; 324
2016; 165
2020; 35
2017; 131
2020; 146
2024; 17
2022; 113
2022; 235
2023; 42
2015; 67
2016; 6
2016; 7
2021; 54
2022; 185
2018; 359
2020; 30
2022; 8
1997; 35
2019; 47
2022; 12
2022; 13
2022; 14
2020; 23
2022; 10
2019; 216
2020; 21
2019; 1872
2022; 19
2023; 31
2010; 54
2017; 7
2021; 27
2021; 21
2021; 29
2023; 9
2019; 129
2020; 54
2019; 365
2022; 378
2019; 363
2020; 8
2023; 21
2006; 60
2020; 5
2014; 5
2023; 27
2021; 39
2020; 44
2012; 338
2023; 10
2021; 7
2021; 6
2023; 14
2023; 18
2020; 580
2015; 95
2023; 16
2017; 23
2022; 43
2014; 111
2006; 313
2021; 13
2021; 97
2021; 12
2021; 11
2021; 18
2021; 19
2024; 42
2011; 45
2016; 533
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_68_1
e_1_2_8_5_1
e_1_2_8_9_1
e_1_2_8_117_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_64_1
e_1_2_8_87_1
e_1_2_8_113_1
e_1_2_8_41_1
e_1_2_8_60_1
e_1_2_8_83_1
e_1_2_8_19_1
e_1_2_8_109_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_57_1
Chen Y. (e_1_2_8_25_1) 2022; 1877
e_1_2_8_120_1
e_1_2_8_91_1
Mezerová K. (e_1_2_8_72_1) 2021; 11
e_1_2_8_95_1
e_1_2_8_99_1
e_1_2_8_105_1
e_1_2_8_128_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_76_1
e_1_2_8_101_1
e_1_2_8_124_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_110_1
e_1_2_8_6_1
e_1_2_8_21_1
e_1_2_8_67_1
e_1_2_8_44_1
e_1_2_8_86_1
e_1_2_8_118_1
e_1_2_8_63_1
e_1_2_8_40_1
e_1_2_8_82_1
e_1_2_8_114_1
e_1_2_8_18_1
e_1_2_8_14_1
e_1_2_8_37_1
e_1_2_8_79_1
e_1_2_8_94_1
e_1_2_8_90_1
e_1_2_8_121_1
e_1_2_8_98_1
e_1_2_8_10_1
e_1_2_8_56_1
e_1_2_8_106_1
e_1_2_8_33_1
e_1_2_8_75_1
e_1_2_8_129_1
e_1_2_8_52_1
e_1_2_8_102_1
e_1_2_8_71_1
e_1_2_8_125_1
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_81_1
e_1_2_8_111_1
e_1_2_8_7_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_66_1
e_1_2_8_89_1
e_1_2_8_119_1
e_1_2_8_62_1
e_1_2_8_85_1
e_1_2_8_115_1
e_1_2_8_17_1
Alizadeh S. (e_1_2_8_3_1) 2020; 23
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_59_1
e_1_2_8_70_1
e_1_2_8_122_1
e_1_2_8_97_1
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_78_1
e_1_2_8_107_1
e_1_2_8_51_1
e_1_2_8_74_1
e_1_2_8_103_1
e_1_2_8_126_1
e_1_2_8_93_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_69_1
Rehm N. (e_1_2_8_84_1) 2021; 13
e_1_2_8_80_1
e_1_2_8_4_1
e_1_2_8_8_1
e_1_2_8_42_1
e_1_2_8_88_1
e_1_2_8_116_1
e_1_2_8_23_1
e_1_2_8_65_1
e_1_2_8_112_1
e_1_2_8_61_1
e_1_2_8_39_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_58_1
e_1_2_8_92_1
e_1_2_8_96_1
e_1_2_8_100_1
e_1_2_8_31_1
e_1_2_8_77_1
e_1_2_8_127_1
e_1_2_8_12_1
e_1_2_8_54_1
e_1_2_8_108_1
e_1_2_8_73_1
e_1_2_8_123_1
e_1_2_8_50_1
e_1_2_8_104_1
References_xml – volume: 6
  issue: 18
  year: 2018
  article-title: Complete genome sequence of AS19, an antibiotic‐sensitive variant of strain B REL606
  publication-title: Genome Announcements
– volume: 21
  issue: 9
  year: 2020
  article-title: Immunological mechanisms in inflammation‐associated colon carcinogenesis
  publication-title: International Journal of Molecular Sciences
– volume: 1872
  start-page: 74
  issue: 1
  year: 2019
  end-page: 79
  article-title: Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation
  publication-title: Biochimica Et Biophysica Acta. Reviews on Cancer
– volume: 17
  issue: 5
  year: 2024
  article-title: Controlled production of lipopolysaccharides increases immune activation in salmonella treatments of cancer
  publication-title: Microbial Biotechnology
– volume: 19
  issue: 18
  year: 2022
  article-title: Colicins and Microcins produced by Enterobacteriaceae: characterization, mode of action, and putative applications
  publication-title: International Journal of Environmental Research and Public Health
– volume: 95
  start-page: 296
  issue: 3
  year: 2015
  end-page: 307
  article-title: Intracellular colon cancer‐associated promote protumoral activities of human macrophages by inducing sustained COX‐2 expression
  publication-title: Laboratory Investigation
– volume: 65
  issue: 7
  year: 2021
  article-title: GyrA tower domain interacts with QnrB1 loop B and plays an important role in QnrB1 protection from quinolone inhibition
  publication-title: Antimicrobial Agents and Chemotherapy
– volume: 54
  start-page: 288
  issue: 1
  year: 2010
  end-page: 297
  article-title: Isolation and characterization of two members of the siderophore‐microcin family, microcins M and H47
  publication-title: Antimicrobial Agents and Chemotherapy
– volume: 10
  start-page: 102
  issue: 1
  year: 2022
  article-title: APTC‐EC‐2A: a lytic phage targeting multidrug resistant planktonic cells and biofilms
  publication-title: Microorganisms
– volume: 276
  start-page: 607
  issue: 5312
  year: 1997
  end-page: 611
  article-title: Prevention of mucosal infection by FimH‐adhesin‐based systemic vaccination
  publication-title: Science
– volume: 113
  start-page: 277
  issue: 1
  year: 2022
  end-page: 286
  article-title: Association of containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan
  publication-title: Cancer Science
– volume: 71
  start-page: 1989
  issue: 5
  year: 2011
  end-page: 1998
  article-title: LPS‐induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin‐mediated cell adhesion and liver metastasis
  publication-title: Cancer Research
– volume: 21
  start-page: 6
  issue: 1
  year: 2023
  end-page: 20
  article-title: Soil microbiomes and one health
  publication-title: Nature Reviews. Microbiology
– volume: 338
  start-page: 120
  issue: 6103
  year: 2012
  end-page: 123
  article-title: Intestinal inflammation targets cancer‐inducing activity of the microbiota
  publication-title: Science
– volume: 42
  issue: 7
  year: 2023
  article-title: Interactions between host and intestinal crypt‐resided biofilms are controlled by epithelial fucosylation
  publication-title: Cell Reports
– volume: 12
  start-page: 4077
  issue: 1
  year: 2021
  article-title: Microbial short‐chain fatty acids modulate CD8 T cell responses and improve adoptive immunotherapy for cancer
  publication-title: Nature Communications
– volume: 13
  start-page: 5914
  issue: 11
  year: 2022
  end-page: 5924
  article-title: Probiotic NISSLE 1917 for inflammatory bowel disease applications
  publication-title: Food & Function
– volume: 277
  start-page: 1453
  issue: 5331
  year: 1997
  end-page: 1462
  article-title: The complete genome sequence of K‐12
  publication-title: Science
– volume: 131
  start-page: 471
  issue: 6
  year: 2017
  end-page: 485
  article-title: Interactions between microsatellite instability and human gut colonization by in colorectal cancer
  publication-title: Clinical Science (London, England)
– volume: 235
  year: 2022
  article-title: Toll‐like receptor 4 (TLR4) inhibitors: current research and prospective
  publication-title: European Journal of Medicinal Chemistry
– volume: 27
  start-page: 203
  issue: 2
  year: 2021
  end-page: 206
  article-title: Cumulative histologic inflammation predicts colorectal neoplasia in ulcerative colitis: a validation study
  publication-title: Inflammatory Bowel Diseases
– volume: 167
  issue: 5
  year: 2021
  article-title: Sustained coevolution of phage lambda and involves inner‐ as well as outer‐membrane defences and counter‐defences
  publication-title: Microbiology (Reading)
– volume: 185
  start-page: 3263
  issue: 17
  year: 2022
  article-title: Intestinal transgene delivery with native chassis allows persistent physiological changes
  publication-title: Cell
– volume: 13
  issue: 8
  year: 2021
  article-title: Escherichiacoli Nissle 1917 as a novel microrobot for tumor‐targeted imaging and therapy
  publication-title: Pharmaceutics
– volume: 146
  start-page: 3147
  issue: 11
  year: 2020
  end-page: 3159
  article-title: Colibactin‐positive induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
  publication-title: International Journal of Cancer
– volume: 313
  start-page: 848
  issue: 5788
  year: 2006
  end-page: 851
  article-title: induces DNA double‐strand breaks in eukaryotic cells
  publication-title: Science
– volume: 21
  start-page: 127
  issue: 1
  year: 2021
  article-title: Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network
  publication-title: BMC Cancer
– volume: 54
  start-page: 431
  issue: 8
  year: 2021
  end-page: 436
  article-title: Acetate decreases PVR/CD155 expression via PI3K/AKT pathway in cancer cells
  publication-title: BMB Reports
– volume: 533
  start-page: 255
  issue: 7602
  year: 2016
  end-page: 259
  article-title: The evolution of cooperation within the gut microbiota
  publication-title: Nature
– volume: 165
  start-page: 842
  issue: 4
  year: 2016
  end-page: 853
  article-title: Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans
  publication-title: Cell
– volume: 30
  start-page: 1401
  issue: 10
  year: 2022
  article-title: Gut commensal outer membrane proteins activate the host food digestive system through neural‐immune communication
  publication-title: Cell Host & Microbe
– volume: 35
  start-page: 2109
  issue: 12
  year: 2020
  end-page: 2121
  article-title: Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions
  publication-title: Journal of Gastroenterology and Hepatology
– volume: 111
  start-page: 18321
  issue: 51
  year: 2014
  end-page: 18326
  article-title: Microbiota organization is a distinct feature of proximal colorectal cancers
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
– volume: 12
  start-page: 426
  issue: 5
  year: 2021
  end-page: 435
  article-title: Unexpected guests in the tumor microenvironment: microbiome in cancer
  publication-title: Protein & Cell
– volume: 60
  start-page: 1136
  issue: 5
  year: 2006
  end-page: 1151
  article-title: Sex and virulence in : an evolutionary perspective
  publication-title: Molecular Microbiology
– volume: 47
  start-page: 5698
  issue: 11
  year: 2019
  end-page: 5711
  article-title: A new role for dam DNA methylase in prevention of aberrant chromosomal replication
  publication-title: Nucleic Acids Research
– volume: 23
  start-page: 886
  issue: 7
  year: 2020
  end-page: 893
  article-title: Anti‐cancer properties of Nissle 1917 against HT‐29 colon cancer cells through regulation of Bax/Bcl‐xL and AKT/PTEN signaling pathways
  publication-title: Iranian Journal of Basic Medical Sciences
– volume: 6
  issue: 4
  year: 2021
  article-title: A toxic friend: genotoxic and mutagenic activity of the probiotic strain Nissle 1917
  publication-title: mSphere
– volume: 97
  year: 2021
  article-title: An oligomeric switch controls the Mrr‐induced SOS response in
  publication-title: DNA Repair (Amst)
– volume: 54
  start-page: 13186
  issue: 20
  year: 2020
  end-page: 13196
  article-title: Chronic exposure to titanium dioxide nanoparticles induces commensal‐to‐pathogen transition in
  publication-title: Environmental Science & Technology
– volume: 8
  issue: 4
  year: 2020
  article-title: Distinguishing Pathovars from Nonpathovars:
  publication-title: Microbiology Spectrum
– volume: 129
  start-page: 1699
  issue: 4
  year: 2019
  end-page: 1712
  article-title: Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
  publication-title: The Journal of Clinical Investigation
– volume: 55
  start-page: 1222
  issue: 3
  year: 2011
  end-page: 1228
  article-title: Antimicrobial resistance in more than 100,000 isolates according to culture site and patient age, gender, and location
  publication-title: Antimicrobial Agents and Chemotherapy
– volume: 67
  start-page: 316
  issue: 2
  year: 2015
  end-page: 326
  article-title: Factors derived from Nissle 1917, grown in different growth media, enhance cell death in a model of 5‐fluorouracil‐induced Caco‐2 intestinal epithelial cell damage
  publication-title: Nutrition and Cancer
– volume: 13
  year: 2022
  article-title: Prevalence, abundance, and virulence of adherent‐invasive in ulcerative colitis, colorectal cancer, and coeliac disease
  publication-title: Frontiers in Immunology
– volume: 8
  issue: 11
  year: 2020
  article-title: Molecular characteristics of Extraintestinal Pathogenic (ExPEC), Uropathogenic (UPEC), and multidrug Resistant isolated from healthy dogs in Spain. Whole genome sequencing of canine ST372 isolates and comparison with human isolates causing Extraintestinal infections
  publication-title: Microorganisms
– volume: 18
  start-page: 314
  issue: 5
  year: 2021
  end-page: 334
  article-title: Gastrointestinal biofilms in health and disease
  publication-title: Nature Reviews. Gastroenterology & Hepatology
– volume: 18
  year: 2023
  article-title: Advances in Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
  publication-title: Materials Today Bio
– volume: 38
  start-page: 130
  issue: 8
  year: 2022
  article-title: Identification of novel biofilm genes in avian pathogenic by Tn5 transposon mutant library
  publication-title: World Journal of Microbiology and Biotechnology
– volume: 163
  start-page: 862
  issue: 4
  year: 2022
  end-page: 874
  article-title: Western‐style diet, pks Island‐carrying , and colorectal cancer: analyses from two large prospective cohort studies
  publication-title: Gastroenterology
– volume: 27
  year: 2023
  article-title: Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer
  publication-title: Translational Oncology
– volume: 20
  start-page: 6560
  issue: 21
  year: 2014
  end-page: 6572
  article-title: Colon cancer‐associated B2 colonize gut mucosa and promote cell proliferation
  publication-title: World Journal of Gastroenterology
– volume: 48
  start-page: 111
  issue: 1
  year: 2003
  end-page: 115
  article-title: Human tumor cells are selectively inhibited by colicins
  publication-title: Folia Microbiologia (Praha)
– volume: 7
  start-page: 54
  issue: 1
  year: 2016
  end-page: 57
  article-title: Do biofilms confer a pro‐carcinogenic state?
  publication-title: Gut Microbes
– volume: 34
  start-page: R517
  issue: 11
  year: 2024
  article-title: One health
  publication-title: Current Biology
– volume: 25
  start-page: 1057
  issue: 7
  year: 2019
  end-page: 1063
  article-title: Programmable bacteria induce durable tumor regression and systemic antitumor immunity
  publication-title: Nature Medicine
– volume: 324
  year: 2023
  article-title: Tumor‐targeting engineered probiotic Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice
  publication-title: Life Sciences
– volume: 31
  start-page: 418
  issue: 3
  year: 2023
  article-title: Tissue‐resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance
  publication-title: Cell Host & Microbe
– volume: 13
  start-page: 1199
  issue: 1
  year: 2022
  end-page: 1215
  article-title: Delivery, structure, and function of bacterial genotoxins
  publication-title: Virulence
– volume: 14
  start-page: 7827
  issue: 1
  year: 2023
  article-title: Contribution of pks(+) mutations to colorectal carcinogenesis
  publication-title: Nature Communications
– volume: 73
  start-page: 233
  issue: 3
  year: 2023
  end-page: 254
  article-title: Colorectal cancer statistics, 2023
  publication-title: CA: a Cancer Journal for Clinicians
– volume: 10
  start-page: 575
  issue: 8
  year: 2012
  end-page: 582
  article-title: A bacterial driver‐passenger model for colorectal cancer: beyond the usual suspects
  publication-title: Nature Reviews. Microbiology
– volume: 23
  start-page: 4422
  year: 2017
  end-page: 4430
  article-title: Analysis of mucosa‐associated microbiota in colorectal cancer
  publication-title: Medical Science Monitor
– volume: 7
  issue: 5
  year: 2021
  article-title: Insights into the acquisition of the pks Island and production of colibactin in the population
  publication-title: Microbial Genomics
– volume: 6
  issue: 3
  year: 2021
  article-title: An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis
  publication-title: Bioengineering & Translational Medicine
– volume: 5
  start-page: 1418
  issue: 11
  year: 2020
  end-page: 1427
  article-title: Mitochondrial dysfunction caused by outer membrane vesicles from gram‐negative bacteria activates intrinsic apoptosis and inflammation
  publication-title: Nature Microbiology
– volume: 30
  start-page: 1146
  issue: 12
  year: 2022
  end-page: 1159
  article-title: The pks Island: a bacterial swiss army knife? Colibactin: beyond DNA damage and cancer
  publication-title: Trends in Microbiology
– volume: 14
  issue: 1
  year: 2022
  article-title: Regulation of flagellar motility and biosynthesis in enterohemorrhagic O157: H7
  publication-title: Gut Microbes
– volume: 2021
  year: 2021
  article-title: The role of fecal Fusobacterium nucleatum and pks(+) as early diagnostic markers of colorectal cancer
  publication-title: Disease Markers
– volume: 17
  issue: 6
  year: 2024
  article-title: Bacterial imaging in tumour diagnosis
  publication-title: Microbial Biotechnology
– volume: 5
  start-page: 4724
  year: 2014
  article-title: Microbial genomic analysis reveals the essential role of inflammation in bacteria‐induced colorectal cancer
  publication-title: Nature Communications
– volume: 7
  start-page: 3446
  issue: 14
  year: 2017
  end-page: 3460
  article-title: rSj16 protects against DSS‐induced colitis by inhibiting the PPAR‐α signaling pathway
  publication-title: Theranostics
– volume: 23
  start-page: 18
  issue: 1
  year: 2017
  end-page: 30
  article-title: Bacterial biofilms in colorectal cancer initiation and progression
  publication-title: Trends in Molecular Medicine
– volume: 11
  issue: 11
  year: 2021
  article-title: Cyclomodulins and hemolysis in as potential low‐cost non‐invasive biomarkers for colorectal cancer screening
  publication-title: Life (Basel)
– volume: 14
  start-page: 733
  year: 2014
  article-title: strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia
  publication-title: BMC Infectious Diseases
– volume: 5
  issue: 6
  year: 2020
  article-title: The polyphosphate kinase of is required for full production of the Genotoxin Colibactin
  publication-title: mSphere
– volume: 1877
  year: 2022
  article-title: Anti‐PD‐1 combined with targeted therapy: theory and practice in gastric and colorectal cancer. Biochimica et biophysica acta
  publication-title: Reviews on Cancer
– volume: 10
  issue: 10
  year: 2023
  article-title: Efficient cytotoxicity of recombinant Azurin in Nissle 1917‐derived Minicells against colon cancer cells
  publication-title: Bioengineering (Basel)
– volume: 14
  year: 2023
  article-title: adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll‐like receptor 4
  publication-title: Frontiers in Immunology
– volume: 29
  start-page: 444
  year: 2022
  end-page: 461
  article-title: Global prevalence and molecular epidemiology of mcr‐mediated colistin resistance in clinical isolates: a systematic review
  publication-title: Journal of Global Antimicrobial Resistance
– volume: 10
  issue: 15
  year: 2023
  article-title: A review of gut microbiota‐derived metabolites in tumor progression and cancer therapy
  publication-title: Advanced Science (Weinheim, Baden‐Wurttemberg, Germany)
– volume: 10
  year: 2020
  article-title: as a multifaceted pathogenic and versatile bacterium
  publication-title: Frontiers in Cellular and Infection Microbiology
– volume: 12
  issue: 530
  year: 2020
  article-title: Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
  publication-title: Science Translational Medicine
– volume: 43
  start-page: 772
  issue: 9
  year: 2022
  end-page: 786
  article-title: Emerging strategies for engineering Nissle 1917‐based therapeutics
  publication-title: Trends in Pharmacological Sciences
– volume: 10
  issue: 3
  year: 2022
  article-title: FimH confers mannose‐targeting ability to bacillus Calmette‐Guerin for improved immunotherapy in bladder cancer
  publication-title: Journal for Immunotherapy of Cancer
– volume: 365
  start-page: 48
  issue: 6448
  year: 2019
  end-page: 53
  article-title: RNA‐guided DNA insertion with CRISPR‐associated transposases
  publication-title: Science
– volume: 359
  start-page: 592
  issue: 6375
  year: 2018
  end-page: 597
  article-title: Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
  publication-title: Science
– volume: 45
  start-page: 10331
  issue: 24
  year: 2011
  end-page: 10336
  article-title: Human‐specific single nucleotide polymorphism (SNP) genotypes detected in a South East Queensland waterway, Australia
  publication-title: Environmental Science & Technology
– volume: 102
  start-page: 10393
  issue: 24
  year: 2018
  end-page: 10408
  article-title: Bacteriocins: perspective for the development of novel anticancer drugs
  publication-title: Applied Microbiology and Biotechnology
– volume: 12
  issue: 1
  year: 2021
  article-title: Evolutionary dynamics based on comparative genomics of pathogenic lineages harboring polyketide synthase (pks) Island
  publication-title: MBio
– volume: 580
  start-page: 269
  issue: 7802
  year: 2020
  end-page: 273
  article-title: Mutational signature in colorectal cancer caused by genotoxic pks(+)
  publication-title: Nature
– volume: 6
  start-page: 147
  issue: 3
  year: 2016
  end-page: 161
  article-title: Insights from 100 years of research with probiotic
  publication-title: European journal of microbiology & immunology
– volume: 15
  issue: 1
  year: 2020
  article-title: Prevalence and association of pks+ with colorectal cancer in patients at the university Malaya medical Centre, Malaysia
  publication-title: PLoS One
– volume: 8
  issue: 2
  year: 2013
  article-title: High prevalence of mucosa‐associated producing cyclomodulin and genotoxin in colon cancer
  publication-title: PLoS One
– volume: 363
  issue: 6428
  year: 2019
  article-title: The human gut bacterial genotoxin colibactin alkylates DNA
  publication-title: Science
– volume: 293
  start-page: 10186
  issue: 26
  year: 2018
  end-page: 10201
  article-title: Lipopolysaccharide (LPS)‐binding protein stimulates CD14‐dependent toll‐like receptor 4 internalization and LPS‐induced TBK1‐IKKϵ‐IRF3 axis activation
  publication-title: The Journal of Biological Chemistry
– volume: 39
  start-page: 708
  issue: 5
  year: 2021
  article-title: Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
  publication-title: Cancer Cell
– volume: 216
  start-page: 2378
  issue: 10
  year: 2019
  end-page: 2393
  article-title: Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis‐associated colorectal cancer
  publication-title: The Journal of Experimental Medicine
– volume: 26
  start-page: 2447
  issue: 11
  year: 2019
  end-page: 2463
  article-title: Gut microbiota‐stimulated cathepsin K secretion mediates TLR4‐dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer
  publication-title: Cell Death and Differentiation
– volume: 42
  start-page: 487
  issue: 3
  year: 2024
  article-title: Improved detection of colibactin‐induced mutations by genotoxic in organoids and colorectal cancer
  publication-title: Cancer Cell
– volume: 12
  year: 2022
  article-title: Phenotypicand genotypic characterization of clinical isolates of intracellular adherent‐invasive among different stages, family history, and treated colorectal cancer patients in Iran
  publication-title: Frontiers in Cellular and Infection Microbiology
– volume: 8
  issue: 28
  year: 2022
  article-title: Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli‐responsive cargo delivery
  publication-title: Science Advances
– volume: 10
  start-page: 4958
  issue: 11
  year: 2020
  end-page: 4966
  article-title: Imaging of tumor colonization by using (18)F‐FDS PET
  publication-title: Theranostics
– volume: 13
  start-page: 59
  issue: 1
  year: 2020
  article-title: diversity: low in colorectal cancer
  publication-title: BMC Medical Genomics
– volume: 16
  start-page: 361
  issue: 6
  year: 2019
  end-page: 375
  article-title: Immunotherapy in colorectal cancer: rationale, challenges and potential
  publication-title: Nature Reviews. Gastroenterology & Hepatology
– volume: 15
  issue: 9
  year: 2019
  article-title: Deciphering the interplay between the genotoxic and probiotic activities of Nissle 1917
  publication-title: PLoS Pathogens
– volume: 29
  start-page: 681
  issue: 5
  year: 2021
  end-page: 688
  article-title: Rethinking phage‐bacteria‐eukaryotic relationships and their influence on human health
  publication-title: Cell Host & Microbe
– volume: 9
  start-page: 3
  issue: 1
  year: 2023
  end-page: 5
  article-title: Gut microbiota–a double‐edged sword in cancer immunotherapy
  publication-title: Trends Cancer
– volume: 12
  issue: 8
  year: 2020
  article-title: Targeting gut microbial biofilms‐a key to hinder colon carcinogenesis?
  publication-title: Cancers (Basel)
– volume: 13
  start-page: 6691
  issue: 1
  year: 2022
  article-title: Inducible plasmid copy number control for synthetic biology in commonly used strains
  publication-title: Nature Communications
– volume: 17
  issue: 5
  year: 2024
  article-title: Ageing, microbes and health
  publication-title: Microbial Biotechnology
– volume: 27
  start-page: 17
  issue: 1
  year: 2019
  end-page: 25
  article-title: Bowel biofilms: tipping points between a healthy and compromised gut?
  publication-title: Trends in Microbiology
– volume: 35
  start-page: 1103
  issue: 5
  year: 1997
  end-page: 1107
  article-title: Age‐specific prevalence of with localized and aggregative adherence in venezuelan infants with acute diarrhea
  publication-title: Journal of Clinical Microbiology
– volume: 378
  issue: 6618
  year: 2022
  article-title: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
  publication-title: Science
– volume: 4
  issue: 5
  year: 2019
  article-title: Altered fecal small RNA profiles in colorectal cancer reflect gut microbiome composition in stool samples
  publication-title: mSystems
– volume: 137
  start-page: 2019
  issue: 8
  year: 2015
  end-page: 2028
  article-title: Induction of CD4( ) and CD8( ) anti‐tumor effector T cell responses by bacteria mediated tumor therapy
  publication-title: International Journal of Cancer
– volume: 30
  start-page: 2297
  issue: 7
  year: 2020
  article-title: Propionic acid promotes the virulent phenotype of crohn's disease‐associated adherent‐invasive
  publication-title: Cell Reports
– volume: 19
  start-page: 37
  issue: 1
  year: 2021
  end-page: 54
  article-title: The population genetics of pathogenic
  publication-title: Nature Reviews. Microbiology
– volume: 13
  issue: 1
  year: 2021
  article-title: Two polyketides intertwined in complex regulation: posttranscriptional CsrA‐mediated control of colibactin and yersiniabactin synthesis in
  publication-title: MBio
– volume: 161
  start-page: 1245
  issue: 4
  year: 2021
  article-title: Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis
  publication-title: Gastroenterology
– volume: 16
  issue: 767
  year: 2023
  article-title: The phosphate‐induced small RNA EsrL promotes virulence, biofilm formation, and intestinal colonization
  publication-title: Science Signaling
– volume: 603
  start-page: 315
  issue: 7900
  year: 2022
  end-page: 320
  article-title: The bacterial toxin colibactin triggers prophage induction
  publication-title: Nature
– volume: 11
  start-page: 1187
  issue: 1
  year: 2020
  article-title: adhesion portion FimH functions as an adjuvant for cancer immunotherapy
  publication-title: Nature Communications
– volume: 7
  start-page: 30
  issue: 1
  year: 2018
  article-title: Bacterial biofilm formation inside colonic crypts may accelerate colorectal carcinogenesis
  publication-title: Clinical and Translational Medicine
– volume: 44
  start-page: 619
  issue: 5
  year: 2018
  end-page: 632
  article-title: and colorectal cancer: a complex relationship that deserves a critical mindset
  publication-title: Critical Reviews in Microbiology
– volume: 47
  start-page: 1511
  issue: 5
  year: 2019
  end-page: 1531
  article-title: RecA and DNA recombination: a review of molecular mechanisms
  publication-title: Biochemical Society Transactions
– volume: 44
  start-page: 655
  issue: 6
  year: 2020
  end-page: 683
  article-title: Structure and genetics of O antigens
  publication-title: FEMS Microbiology Reviews
– volume: 67
  start-page: 553
  issue: 8
  year: 2021
  end-page: 571
  article-title: A review of the taxonomy, genetics, and biology of the genus Escherichia and the type species
  publication-title: Canadian Journal of Microbiology
– ident: e_1_2_8_129_1
  doi: 10.1084/jem.20181939
– ident: e_1_2_8_89_1
  doi: 10.1021/es201599u
– volume: 23
  start-page: 886
  issue: 7
  year: 2020
  ident: e_1_2_8_3_1
  article-title: Anti‐cancer properties of Escherichia coli Nissle 1917 against HT‐29 colon cancer cells through regulation of Bax/Bcl‐xL and AKT/PTEN signaling pathways
  publication-title: Iranian Journal of Basic Medical Sciences
– ident: e_1_2_8_83_1
  doi: 10.1186/s40169-018-0209-2
– ident: e_1_2_8_96_1
  doi: 10.1128/mBio.03634-20
– ident: e_1_2_8_103_1
  doi: 10.5483/BMBRep.2021.54.8.060
– ident: e_1_2_8_22_1
  doi: 10.1038/s41467-023-43329-5
– ident: e_1_2_8_47_1
  doi: 10.3390/microorganisms10010102
– ident: e_1_2_8_60_1
  doi: 10.1016/j.molmed.2016.11.004
– ident: e_1_2_8_68_1
  doi: 10.1016/j.tips.2022.02.002
– ident: e_1_2_8_95_1
  doi: 10.1080/19490976.2022.2110822
– ident: e_1_2_8_99_1
  doi: 10.1128/mSphere.01195-20
– ident: e_1_2_8_106_1
  doi: 10.1128/AAC.00744-09
– ident: e_1_2_8_37_1
  doi: 10.1080/21505594.2022.2097417
– ident: e_1_2_8_50_1
  doi: 10.1007/s11274-022-03314-4
– ident: e_1_2_8_28_1
  doi: 10.1111/1751-7915.14474
– ident: e_1_2_8_49_1
  doi: 10.1158/0008-5472.CAN-10-2833
– ident: e_1_2_8_126_1
  doi: 10.1136/jitc-2021-003939
– ident: e_1_2_8_34_1
  doi: 10.1042/BST20190558
– ident: e_1_2_8_45_1
  doi: 10.1126/scitranslmed.aax0876
– ident: e_1_2_8_122_1
  doi: 10.1021/acs.est.0c04968
– volume: 13
  issue: 1
  year: 2021
  ident: e_1_2_8_84_1
  article-title: Two polyketides intertwined in complex regulation: posttranscriptional CsrA‐mediated control of colibactin and yersiniabactin synthesis in Escherichia coli
  publication-title: MBio
  doi: 10.1128/mbio.03814-21
– ident: e_1_2_8_33_1
  doi: 10.1073/pnas.1406199111
– ident: e_1_2_8_32_1
  doi: 10.1080/19490976.2015.1121363
– ident: e_1_2_8_70_1
  doi: 10.3390/ijerph191811825
– ident: e_1_2_8_119_1
  doi: 10.1002/advs.202207366
– ident: e_1_2_8_94_1
  doi: 10.1126/science.aax9181
– ident: e_1_2_8_9_1
  doi: 10.1128/genomeA.00385-18
– ident: e_1_2_8_39_1
  doi: 10.1042/CS20160876
– ident: e_1_2_8_123_1
  doi: 10.1038/s41467-020-15030-4
– ident: e_1_2_8_98_1
  doi: 10.1186/s12920-020-0704-3
– ident: e_1_2_8_38_1
  doi: 10.3390/microorganisms8111712
– ident: e_1_2_8_100_1
  doi: 10.1128/mSystems.00289-19
– ident: e_1_2_8_116_1
  doi: 10.1007/s13238-020-00813-8
– ident: e_1_2_8_63_1
  doi: 10.1155/2021/1171239
– ident: e_1_2_8_120_1
  doi: 10.1139/cjm-2020-0508
– ident: e_1_2_8_92_1
  doi: 10.1038/s41586-022-04444-3
– ident: e_1_2_8_118_1
  doi: 10.12659/MSM.904220
– ident: e_1_2_8_61_1
  doi: 10.1016/j.bbcan.2019.05.009
– ident: e_1_2_8_62_1
  doi: 10.1093/femsre/fuz028
– ident: e_1_2_8_78_1
  doi: 10.1038/s41586-020-2080-8
– volume: 11
  issue: 11
  year: 2021
  ident: e_1_2_8_72_1
  article-title: Cyclomodulins and hemolysis in E. Coli as potential low‐cost non‐invasive biomarkers for colorectal cancer screening
  publication-title: Life (Basel)
– ident: e_1_2_8_97_1
  doi: 10.1016/j.lfs.2023.121709
– ident: e_1_2_8_114_1
  doi: 10.1126/science.aar7785
– ident: e_1_2_8_2_1
  doi: 10.1126/sciadv.abo6163
– ident: e_1_2_8_86_1
  doi: 10.1016/j.ccell.2024.02.009
– ident: e_1_2_8_124_1
  doi: 10.3389/fimmu.2023.1213467
– ident: e_1_2_8_80_1
  doi: 10.3748/wjg.v20.i21.6560
– ident: e_1_2_8_53_1
  doi: 10.1126/scisignal.abm0488
– ident: e_1_2_8_76_1
  doi: 10.1016/j.celrep.2020.01.078
– ident: e_1_2_8_17_1
  doi: 10.3389/fcimb.2020.548492
– ident: e_1_2_8_77_1
  doi: 10.1111/1751-7915.14477
– ident: e_1_2_8_52_1
  doi: 10.1371/journal.pone.0228217
– ident: e_1_2_8_16_1
  doi: 10.1016/j.dnarep.2020.103009
– ident: e_1_2_8_42_1
  doi: 10.1016/j.chom.2022.08.004
– ident: e_1_2_8_112_1
  doi: 10.1556/1886.2016.00029
– ident: e_1_2_8_65_1
  doi: 10.1002/ijc.32920
– ident: e_1_2_8_57_1
  doi: 10.1186/s12879-014-0733-7
– ident: e_1_2_8_31_1
  doi: 10.1126/science.aah3648
– ident: e_1_2_8_109_1
  doi: 10.1080/01635581.2015.990570
– ident: e_1_2_8_82_1
  doi: 10.1038/nature17626
– ident: e_1_2_8_18_1
  doi: 10.1371/journal.pone.0056964
– ident: e_1_2_8_67_1
  doi: 10.1038/s41467-021-24331-1
– ident: e_1_2_8_93_1
  doi: 10.1002/ijc.29567
– ident: e_1_2_8_15_1
  doi: 10.1126/science.277.5331.1453
– ident: e_1_2_8_107_1
  doi: 10.1016/j.cell.2016.04.007
– ident: e_1_2_8_43_1
  doi: 10.1128/jcm.35.5.1103-1107.1997
– ident: e_1_2_8_20_1
  doi: 10.1126/science.abm3233
– ident: e_1_2_8_29_1
  doi: 10.1007/BF02931286
– ident: e_1_2_8_87_1
  doi: 10.1016/j.cell.2022.06.050
– ident: e_1_2_8_40_1
  doi: 10.1038/s41575-019-0126-x
– ident: e_1_2_8_41_1
  doi: 10.1111/jgh.15077
– ident: e_1_2_8_14_1
  doi: 10.1016/j.cub.2024.04.025
– ident: e_1_2_8_8_1
  doi: 10.1099/mgen.0.000579
– ident: e_1_2_8_23_1
  doi: 10.1128/AAC.00402-21
– ident: e_1_2_8_101_1
  doi: 10.1038/nrmicro2819
– ident: e_1_2_8_21_1
  doi: 10.1016/j.tim.2022.05.010
– ident: e_1_2_8_56_1
  doi: 10.7150/thno.42121
– ident: e_1_2_8_85_1
  doi: 10.1128/microbiolspec.AME-0014-2020
– ident: e_1_2_8_113_1
  doi: 10.1080/1040841X.2018.1481013
– ident: e_1_2_8_121_1
  doi: 10.1093/ibd/izaa047
– ident: e_1_2_8_110_1
  doi: 10.1002/btm2.10219
– ident: e_1_2_8_73_1
  doi: 10.1038/s41575-020-00397-y
– ident: e_1_2_8_88_1
  doi: 10.1128/AAC.00765-10
– ident: e_1_2_8_127_1
  doi: 10.1016/j.ejmech.2022.114291
– ident: e_1_2_8_111_1
  doi: 10.7150/thno.20359
– ident: e_1_2_8_11_1
  doi: 10.1038/s41579-022-00779-w
– ident: e_1_2_8_5_1
  doi: 10.1053/j.gastro.2022.06.054
– ident: e_1_2_8_7_1
  doi: 10.1126/science.1224820
– ident: e_1_2_8_125_1
  doi: 10.1016/j.chom.2023.01.013
– ident: e_1_2_8_115_1
  doi: 10.1111/j.1365-2958.2006.05172.x
– ident: e_1_2_8_10_1
  doi: 10.1007/s00253-018-9420-8
– ident: e_1_2_8_128_1
  doi: 10.1039/D2FO00226D
– ident: e_1_2_8_71_1
  doi: 10.1371/journal.ppat.1008029
– ident: e_1_2_8_12_1
  doi: 10.1053/j.gastro.2021.06.024
– ident: e_1_2_8_66_1
  doi: 10.3389/fimmu.2022.748839
– ident: e_1_2_8_19_1
  doi: 10.1099/mic.0.001063
– ident: e_1_2_8_79_1
  doi: 10.1093/nar/gkz242
– ident: e_1_2_8_6_1
  doi: 10.1038/ncomms5724
– ident: e_1_2_8_44_1
  doi: 10.1016/j.celrep.2023.112754
– ident: e_1_2_8_46_1
  doi: 10.3390/ijms21093062
– ident: e_1_2_8_64_1
  doi: 10.3390/pharmaceutics13081226
– ident: e_1_2_8_26_1
  doi: 10.3390/cancers12082272
– ident: e_1_2_8_105_1
  doi: 10.1016/j.tim.2018.08.009
– ident: e_1_2_8_59_1
  doi: 10.1038/s41418-019-0312-y
– ident: e_1_2_8_48_1
  doi: 10.1111/1751-7915.14461
– ident: e_1_2_8_90_1
  doi: 10.1016/j.tranon.2022.101598
– ident: e_1_2_8_104_1
  doi: 10.1074/jbc.M117.796631
– ident: e_1_2_8_35_1
  doi: 10.1038/s41579-020-0416-x
– ident: e_1_2_8_75_1
  doi: 10.1126/science.1127059
– ident: e_1_2_8_36_1
  doi: 10.1038/s41564-020-0773-2
– ident: e_1_2_8_74_1
  doi: 10.1128/mSphere.00624-21
– ident: e_1_2_8_24_1
  doi: 10.1016/j.mtbio.2023.100543
– ident: e_1_2_8_102_1
  doi: 10.1172/JCI124196
– ident: e_1_2_8_117_1
  doi: 10.1186/s12885-021-07845-1
– ident: e_1_2_8_55_1
  doi: 10.3389/fcimb.2022.938477
– ident: e_1_2_8_51_1
  doi: 10.1111/cas.15196
– ident: e_1_2_8_108_1
  doi: 10.1016/j.chom.2021.02.007
– ident: e_1_2_8_4_1
  doi: 10.1016/j.trecan.2022.08.003
– ident: e_1_2_8_27_1
  doi: 10.1038/s41591-019-0498-z
– ident: e_1_2_8_54_1
  doi: 10.1038/s41467-022-34390-7
– ident: e_1_2_8_13_1
  doi: 10.1016/j.ccell.2021.03.004
– ident: e_1_2_8_30_1
  doi: 10.1016/j.jgar.2021.10.022
– ident: e_1_2_8_81_1
  doi: 10.1038/labinvest.2014.161
– ident: e_1_2_8_91_1
  doi: 10.3322/caac.21772
– volume: 1877
  year: 2022
  ident: e_1_2_8_25_1
  article-title: Anti‐PD‐1 combined with targeted therapy: theory and practice in gastric and colorectal cancer. Biochimica et biophysica acta
  publication-title: Reviews on Cancer
– ident: e_1_2_8_58_1
  doi: 10.1126/science.276.5312.607
– ident: e_1_2_8_69_1
  doi: 10.3390/bioengineering10101188
SSID ssj0060052
Score 2.4038117
SecondaryResourceType review_article
Snippet Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In...
Escherichia coli ( E. coli ) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its functions. In...
Abstract Escherichia coli (E. coli) is a ubiquitous symbiotic bacterium in the gut, and the diversity of E. coli genes determines the diversity of its...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e70029
SubjectTerms Antigens
Bacteria
Biofilms
Biomarkers
Cancer therapies
Coliforms
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - microbiology
DNA methylation
E coli
Environmental factors
Escherichia coli
Escherichia coli - genetics
Gastrointestinal Microbiome
Genes
Genetic engineering
Genomes
Humans
Immunotherapy
Metabolism
Metabolites
Metastasis
Microflora
Microorganisms
Nanoparticles
Phylogenetics
Polymorphism
Probiotics
Review
Science
Tumors
SummonAdditionalLinks – databaseName: DOAJ - Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTtwwEB5VnOihakt_UigKEodeAhv_JA43QCCEBCeQuFke21FXqpIKFvXKI_CMPElnnOxqVy3iwilRYkfWN2PPjDP-BmAXZeQzjhSdKBkKpZ0sTFlWBTIXmZIR25YPJ19cVmfX6vxG3yyV-uKcsIEeeABun8IV58ntrtGQsqF3DTaCayP71pFpSTyfZPPmwdSwBle82zkS-XDeDtnIkokZ9V7Nv6FWbFCi6v-ff_lvmuSy-5rsz-l7eDc6jvnhMOAP8CZ2H-HtEp3gBhyc3LEIppy-nJOAp3nf8bXnVY36epbw7UF-mM_-9E8Pj7yVFnLOEgyf4Pr05Or4rBhrIxReS90UUSisvTCaQYktIatDFA4FMs-nDHUjHMHkja-llM5o473gc-M4abCUSn6Gta7v4lfIyygm2MrKhKCU8miCdogYNLWV9NEM9uZoWT8Sh3P9il92HkAwvJbhtQneDH4sOvweODOeb3rE8C-aMdl1ekAqYEcVsC-pQAZbc-HZcQbeWcm0GRQ9GZXBzuI1zR3-IeK62N9zG_JGmWBQZ_BlkPViJKlivFKTDMyKFqwMdfVNN_2Z-LkpxKxFpcsM9pPCvASCvTi6Eunu22vAsQnrgjyvIeNwC9Zmt_fxO3lOM9xOk-QvticPaA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwEB6V9gIHBKVASkFB4tBL2o0fidMLalG3VaVyaqXeLL8CK1VJ2d2Ka38Cv5FfwozXWbri0VOi2I7sedgz9vgbgA-WB7rjiN6J4L4Q0vBClWVVWMIiEzzYtqXLyeefq9NLcXYlr9KG2yyFVQ5zYpyofe9oj3yfEwwCWsNKfLz5VlDWKDpdTSk0HsFGiSsNhXSp8ckwE1e055ngfCh6B1fKkuAZ5V5Nh1ErK1EE7P-blflnsOR9IzauQuNn8DSZj_nhgt_PYS10m_DkHqjgCzg4nhEjJhTEnCObJ3nf0bOnuQ3bOuLz9CA_zOff-593P2hDzecUK-i34HJ8fPHptEgZEgonuWyKwIStHVMS9dCGFukrfWDGMkton9zXDTOsrJxyNefcKKmcY3R73I4aW3LBX8J613fhNeRlYCPb8kp5L4RwVnlprLVeYl2OP81gb6CWdgk-nLJYXOvBjSDyaiKvjuTNYHfZ4GaBnPHvqkdE_mU1gryOH_rpF500SKPfahz6X7VVNFpnGtswSpLtWoM2Bs9gZ2CeTno407-lJoP3y2LUIDoWMV3ob6kO2qQEMygzeLXg9bInMW-8EKMM1IoUrHR1taSbfI0o3eho1qySZQb7UWAeIoI-P7pg8W37_yN5A48ZWlaLiMIdWJ9Pb8NbtIzm9l0U_19RtQeK
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BucAB8SZQUJA4cEnZ-JE4vbWoVYVUxKGVuFke24GVUIJ2t-LKT-A38kuYcR7a5SHEKVE8tpwZjz1jz3wGeIkyco4jeSdKhkJpJwtTllWBjEWmZMS25eTk83fV2aV6-0FP0YScCzPgQ8wbbqwZab5mBXe43lJyWvdKBlvUBzUfLV2HG5xgy1F9Qr2fJuOKtz1TTuRIPKL7cDDPLw3sLEwJv_9PRufvsZPbNm1alE7vwO3RmsyPBvHfhWuxuwe3tjAG78PhyZrlsuSY5pykvsz7jp89T3VU17PYV4f5Ub752v_49p3310LOoYPhAVyenly8OSvGCxMKr6VuiigU1l4YTWqJsSV26xCFQ4EM_ilD3QgnysobX0spndHGe8HJ5LhosJRKPoS9ru_iY8jLKBbYysqEoJTyaIJ2iBg00UpqNIODiVvWj2jifKnFZzt5Fcxey-y1ib0ZvJorfBmANP5Oeszsn8kYATt96Fcf7ahQltxY58kdq9Hw33rXYCP4zmzfOjI5ZAb7k_DsqJZrKxlLg1wqozJ4MReTQvEpietif8U0ZKIy6qDO4NEg67kn6Rp5pRYZmJ1RsNPV3ZJu-SmBdtPgrEWlywxepwHzLybY8-MLkd6e_HeNp3BTkO01xBzuw95mdRWfke20wedJO34CtMALIA
  priority: 102
  providerName: Wiley-Blackwell
Title Escherichia coli on colorectal cancer: A two‐edged sword
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1751-7915.70029
https://www.ncbi.nlm.nih.gov/pubmed/39400440
https://www.proquest.com/docview/3121511884
https://www.proquest.com/docview/3116338995
https://pubmed.ncbi.nlm.nih.gov/PMC11472651
https://doaj.org/article/446ac8627b8048bca9b921603cfa6143
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED-x7YkHxH8CowoSD7ykNP4TO5MQWlHLhNRpQqvUt8h2HKg0JdB1At74CHxGPgl3bhJWUYTESxLFduLc-XJ39vl3AM8t97THEb0TwctESMMTnaZZYgmLTHBvq4o2J89Os5O5eLeQi9_pgFoCXu507Sif1Hx1Mfz6-dtrFPhXXVQOasCUYBflUNEi0x4coFpSlM5gJvolhYwmQFtsnx2NttRSQO_fZXL-GTl53aINKml6G261tmR8vGH-Hbjh67tw8xrC4D04mlwSV5YU0Rwjz5dxU9O5oR8dtnXE9NVRfByvvzQ_v_-g2bUypsDB8j7Mp5PzNydJmy4hcZLLPPFMWOWYliiU1ldIbFl6ZiyzBP3JS5Uzw9LMaac450ZL7RyjreR2lNuUC_4A9uum9o8gTj0b2YpnuiyFEM7qUhprbSmxLseHRjDsqFW4FkucUlpcFJ1PQeQtiLxFIG8EL_oGnzYwGn-vOiby99UI_zrcaFYfilacCnRijUNnTFlNX-tMbnNGGbNdZdDg4BEcdswrujFVcELSQIdKiwie9cUoTrRGYmrfXFEdNFAJc1BG8HDD674nIYm8EKMI9NYo2Orqdkm9_Bggu9HrVCyTaQQvw4D5FxGK2fichavH__-yJzQJ0UYspoewv15d-adoQq3tAPaYOMOjWig86unbARyMJ6dn7wdhUmIQROcXesAa6Q
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VcoAeEG8CBYIEEpe0Gz8SpxJCLXTZ0m5PW6k3Ez9CV0JJ2d2q4sZP4Jfwo_glzHiTpStep54SxXZkj2fsGXvmG4DnhnuKcUTrRHCXCFnyRKVplhjCIhPcm6qi4OThYTY4Eu-P5fEKfO9iYcitslsTw0LtGktn5JucYBBQG1bi9ennhLJG0e1ql0Jjzhb7_ss5mmzTV3tvcX5fMNbfHb0ZJG1WgcRKLovEM2Fyy5RE3jW-wj5J51lpmCGETO7ygpUszayyOee8VFJZyyji2vQKk3LB8b9X4KrguJNTZHr_XbfyZ3TG2sIHkbcQ7swpwUHKjZwuv5Z2vpAg4E9a7e_OmReV5rDr9W_CjVZdjbfn_HULVnx9G9YugBjega3dKU38mJymY2SrcdzU9GxoLcW2lvhqshVvx7Pz5sfXb3SA52LyTXR34ehSaHcPVuum9g8gTj3rmYpnyjkhhDXKydIY4yTW5fjTCDY6amnbwpVT1oxPujNbiLyayKsDeSN4uWhwOkfq-HvVHSL_ohpBbIcPzeSjbiVWo51cWrT3cqNotLYsTMEoKbetStRpeATr3eTpVu6n-heXRvBsUYwSS9cwZe2bM6qDOjDBGsoI7s_netGTkKdeiF4EaokLlrq6XFKPTwIqOBq2OctkGsFmYJj_EUEPd0YsvD3890iewrXBaHigD_YO9x_BdYZa3dybcR1WZ5Mz_xi1spl5EkQhhg-XLXs_AQlRQiw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVELwgLhjKGAkkHhxE-_F3lRCqKGJWkqjCrVS37bei2mkyi5Jqoo3PoHv4XP4EmZ8CY24PfXJlr22dmfP7M7szp4BeGm4pzOO6J0I7iIhMx6pOE4iQ1xkgnuT53Q4eW-cbB-K90fyaAW-t2dhKKyyHROrgdqVltbIu5xoENAaVqKbN2ER-1ujt2efI8ogRTutbTqNGiK7_ssFum-zNztb2NevGBsND95tR02GgchKLvuRZ8KklimJODY-x_pJ51lmmCG2TO7SPstYnFhlU855pqSyltHpa9Prm5gLjv-9BqspeUUdWB0Mx_sf23kgoRXXhkyIYodwno6JHFKup7QVtjQPVukC_mTj_h6qedmErubA0W241Riv4WaNtjuw4ou7cPMSpeE92BjOCAYTCqEOEWSTsCzoWtLIit9aQtl0I9wM5xflj6_faDnPhRSp6O7D4ZVI7wF0irLwjyCMPeuZnCfKOSGENcrJzBjjJJbl-NMA1ltpaduQl1MOjVPdOjEkXk3i1ZV4A3i9-OCs5u34e9EBiX9RjAi3qwfl9JNu9Fej15xZ9P5So6i1NuubPqMU3TbP0MLhAay1naebUWCmf2E2gBeL16i_tCmTFb48pzJoERPJoQzgYd3Xi5pUWeuF6AWgllCwVNXlN8XkpOIIRzc3ZYmMA-hWgPmfEPTe4IBVd4__3ZLncB31Tn_YGe8-gRsMTbw6tHENOvPpuX-KJtrcPGt0IYTjq1a_n9B0R74
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Escherichia+coli+on+colorectal+cancer%3A+A+two%E2%80%90edged+sword&rft.jtitle=Microbial+biotechnology&rft.au=Jian%2C+Chu&rft.au=Yinhang%2C+Wu&rft.au=Jing%2C+Zhuang&rft.au=Zhanbo%2C+Qu&rft.date=2024-10-01&rft.pub=John+Wiley+and+Sons+Inc&rft.eissn=1751-7915&rft.volume=17&rft.issue=10&rft_id=info:doi/10.1111%2F1751-7915.70029&rft.externalDocID=PMC11472651
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1751-7915&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1751-7915&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1751-7915&client=summon